Page 68 - IMO-2-2

Innovative Medicines & Omics Open source bioinformatics tools in Africa

neglected tropical diseases using open-access bioinformatics doi: 10.1126/science.1259657
tools. Parasit Vectors. 2020;13(1):567-579.
44. Faye O, Boëlle PY, Heleze E, et al. Chains of transmission
doi: 10.1186/s13071-020-04376-w and control of Ebola virus disease in Conakry, Guinea, in
2014: An observational study. Lancet Infect Dis. 2015;15(3):
33. Tiffin N, Otieno A, Ndegwa N, et al. Leveraging African
open-access resources for biomedical informatics. BMC 320-326.
Med Inform Decis Mak. 2020;20(1):1-13. doi: 10.1016/S1473-3099(14)71075-8
doi: 10.1186/s12911-020-01210-1 45. Sahin A, Conteh S, Koroma B, Marah L. Real-time tracking
of the Ebola virus outbreak in Sierra Leone using Nextstrain.
34. Joubert F, Aron S. Open data-sharing in African genomics:
A roadmap for success. BMC Genomics. 2023;24(1):78-91. Infect Dis Rep. 2019;11(4):320-327.
doi: 10.3390/idr11040034
doi: 10.1186/s12864-023-09623-7
46. World Health Organization. Ebola Virus Disease-Democratic
35. Diallo A, Manneh J, Keita M, et al. Developing computational
biology expertise in Africa: Lessons from H3ABioNet. Brief Republic of the Congo. World Health Organization; 2019.
Bioinform. 2021;22(2):146-160. Available from: https://www.who.int/emergencies/disease-
outbreak-news/item/06-june-2019-ebola-drc [Last accessed
doi: 10.1093/bib/bbaa257 on 2024 Apr 09].
36. Wilkinson E, Smout C, Barbera M, et al. African genomic 47. Tegally H, Wilkinson E, Giovanetti M, et al. Detection of
surveillance of infectious diseases: Challenges and progress. a SARS-CoV-2 variant of concern in South Africa. Nature.
Nat Commun. 2021;12(1):567-581. 2021;592(7854):438-443.
doi: 10.1038/s41467-021-20942-x doi: 10.1038/s41586-020-03106-7
37. Yemi T, Adeyemi O, Olayemi A, et al. The future of open- 48. Eshun-Wilson I, Smith J, Moyo L. Genomic surveillance of
source bioinformatics in Africa: Opportunities and risks. SARS-CoV-2 in South Africa: Early detection of variants.
PLoS Digit Health. 2022;1(5):e0000015. Nat Genet. 2021;53(2):270-275.
doi: 10.1371/journal.pdig.0000015 doi: 10.1038/s41588-020-00779-5
38. Mkhize S, Ndlovu S, Molefe T. Harnessing the PDB for 49. Ndounga M, Ntoumi F, Mbacham WF. Genetic markers
tuberculosis research: A focus on drug resistance in of artemisinin resistance in Plasmodium falciparum:
Southern Africa. BMC Bioinformatics. 2020;21(1):105. Implications for malaria control in Africa. Malar J.
2020;19(1):1-10.
doi: 10.1186/s12859-020-3377-x
doi: 10.1186/s12936-020-03331-4
39. Mkhize S, Zungu L, Ngcobo S. Molecular docking of
antimicrobial compounds against multidrug-resistant 50. Lwanga J, Kyeyune R, Namugenyi P, Oloya J, Tumwine J.
tuberculosis: Insights from South Africa. BMC Pharmacol In silico discovery of novel antimalarial compounds using
Toxicol. 2020;21(1):24. AutoDock: Insights from Ugandan medicinal plants. Afr J
Biotechnol. 2018;17(25):783-794.
doi: 10.1186/s40360-020-00426-4
doi: 10.5897/AJB2018.16594
40. Ogunrinde TJ, Adeyemo WL, Balogun WG. Genomic
analysis of sickle cell anemia in Nigeria: Implications for 51. Mkhize N, Dlamini S, Pillay M. Molecular dynamics
personalized medicine. BMC Genomics. 2019;20(1):1-10. simulations in tuberculosis drug discovery: A South African
perspective. J Mol Graph Model. 2020;98:107-115.
doi: 10.1186/s12864-019-6125-4
41. Wonkam A, Makani J. Sickle cell disease in Africa: doi: 10.1016/j.jmgm.2019.107110
An overview of the integrated approach to health, 52. Kibet CK, Macharia JM, Ngugi CW. Computational drug
research, education and advocacy. South African Med J. discovery for HIV in Africa: Challenges and opportunities.
2019;109(1):40-46. Front Pharmacol. 2021;12:678.
doi: 10.7196/SAMJ.2019.v109i1.13757 doi: 10.3389/fphar.2021.00678
42. Ngugi R, Kimenju S, Wang Z. Genomic insights into 53. Amoah LE, Kusi KA, Ofori MF. Computational approaches
drought tolerance in maize: A case study from Kenya. Afr J to antimalarial drug discovery in Africa. J Bioinform Comput
Biotechnol. 2020;19(8):543-552. Biol. 2020;18(3):1-15.
doi: 10.5897/AJB2020.17219 doi: 10.1142/S0219720020500197
43. Gire SK, Goba A, Andersen KG, et al. Genomic surveillance 54. Mushi MF, Mshana SE, Kidenya BR. ADMET analysis
elucidates Ebola virus origin and transmission during the of natural compounds for drug discovery in Tanzania.
2014 outbreak. Science. 2014;345(6202):1369-1372. J Ethnopharmacol. 2019;245:112-120.

Volume 2 Issue 2 (2025) 62 doi: 10.36922/imo.8111